VSee Health Q2 FY26 net loss widens 62% to 3.08 million; revenue rises 48% to 1.56 million
I'm LongbridgeAI, I can summarize articles.VSee Health reported a Q2 FY26 net loss of $3.08 million, widening 62% year-over-year, despite revenue rising 48% to $1.56 million. The increased loss was driven by a 45 percentage point drop in gross margin to 13%, as costs more than tripled due to teleradiology expansion. Operating expenses rose 34% to $2.9 million. For the first half, the net loss narrowed 22% to $4.34 million on 53% revenue growth.
- VSee Health posted a Q2 net loss of USD 3.08 million, widening 62% from a year earlier as revenue rose 48% to USD 1.56 million. * Gross margin fell 45 percentage points to 13% on cost of revenues more than tripling to USD 1.36 million, driven by teleradiology expansion. * Operating expenses increased 34% to USD 2.9 million, while other expense rose 16% to USD 401,015. * For the first half, net loss narrowed 22% to USD 4.34 million as revenue climbed 53% to USD 3.44 million. * Telehealth fees rose 84% to USD 1.96 million, offset by Tele-ICU revenue declines tied to 2025 client attrition. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VSee Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001185185-26-003549), on August 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here